Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexinidazole Effectiveness and Safety in g-HAT
NCT03025789Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Nov 2016
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Fexinidazole in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started Nov 2016; status: completed.
02
Drugs
Fexinidazole
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT03025789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03025789.